GeneNews Limited announced a strategic restructuring, including senior management changes and staff reductions, designed to further position its recently formed joint venture, Innovative Diagnostic Laboratory LLP, to become a leader in molecular diagnostics and personalized medicine, with a primary focus on cancer-related indications. With many of the necessary preparations for the IDL launch now complete, and in connection with the restructuring, GeneNews announced the departure of Gailina J. Liew, its President and Chief Operating Officer. Ms. Liew has also resigned from the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -.--% | -.--% | -11.11% |
05-21 | Transcript : StageZero Life Sciences Ltd., Q1 2024 Earnings Call, May 21, 2024 | |
05-16 | StageZero Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 3.61M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+38.17% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- SZLS Stock
- News StageZero Life Sciences Ltd.
- GeneNews Limited Announces Executive Changes